Education
About Us
Working with TipRanks
Follow Us
Lotus Eye Hospital And Institute Ltd (IN:LOTUSEYE)
:LOTUSEYE
Total Valuation
Lotus Eye Hospital And Institute Ltd has a market cap or net worth of ₹2.42B. The enterprise value is ―.
Market Cap₹2.42B
Enterprise Value―
Share Statistics
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,796,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lotus Eye Hospital And Institute Ltd’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 0.35%.
Return on Equity (ROE)0.01
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)0.35%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee1.48M
Profits Per Employee22.00K
Employee Count336
Asset Turnover0.71
Inventory Turnover10.32
Valuation Ratios
The current PE Ratio of Lotus Eye Hospital And Institute Ltd is 371.3. Lotus Eye Hospital And Institute Ltd’s PEG ratio is -2.60.
PE Ratio371.3
PS Ratio2.94
PB Ratio2.43
Price to Fair Value2.43
Price to FCF-68.62
Price to Operating Cash Flow0.00
PEG Ratio-2.60
Income Statement
In the last 12 months, Lotus Eye Hospital And Institute Ltd had revenue of 495.63M and earned 7.39M in profits. Earnings per share was 0.34.
Revenue495.63M
Gross Profit100.41M
Operating Income4.26M
Pretax Income13.83M
Net Income7.39M
EBITDA47.44M
Earnings Per Share (EPS)0.34
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Lotus Eye Hospital And Institute Ltd pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change75.29%
50-Day Moving Average113.02
200-Day Moving Average80.10
Relative Strength Index (RSI)46.03
Average Volume (3m)3.63K
Important Dates
Lotus Eye Hospital And Institute Ltd upcoming earnings date is Nov 18, 2025, TBA (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend DateSep 18, 2023
Financial Position
Lotus Eye Hospital And Institute Ltd as a current ratio of 1.56, with Debt / Equity ratio of 0.00%
Current Ratio1.56
Quick Ratio1.04
Debt to Market Cap<0.01
Net Debt to EBITDA0.30
Interest Coverage Ratio1.20
Taxes
In the past 12 months, Lotus Eye Hospital And Institute Ltd has paid 6.43M in taxes.
Income Tax6.43M
Effective Tax Rate0.47
Enterprise Valuation
Lotus Eye Hospital And Institute Ltd EV to EBITDA ratio is 31.03, with an EV/FCF ratio of -69.28.
EV to Sales2.97
EV to EBITDA31.03
EV to Free Cash Flow-69.28
EV to Operating Cash Flow54.48
Balance Sheet
Lotus Eye Hospital And Institute Ltd has ₹41.51M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹41.51M billion.
Cash & Marketable Securities₹41.51M
Total Debt₹0.00
Net Cash₹41.51M
Net Cash Per Share₹2.00
Tangible Book Value Per Share₹27.54
Margins
Gross margin is 44.43%, with operating margin of 0.86%, and net profit margin of 1.49%.
Gross Margin44.43%
Operating Margin0.86%
Pretax Margin2.79%
Net Profit Margin1.49%
EBITDA Margin9.57%
EBIT Margin3.51%
Analyst Forecast
The average price target for Lotus Eye Hospital And Institute Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.41%
EPS Growth Forecast-69.33%